No major effect of the CD28/CTLA4/ICOS gene region on susceptibility to primary sclerosing cholangitis

Scandinavian Journal of Gastroenterology

Volumn 41, Issue 5, 2006, Pages 586-591

  Wiencke, Kristine ^a,b   Boberg, Kirsten Muri ^a   Donaldson, Peter ^c   Harbo, Hanne ^b   Ling, Vincent ^d   Schrumpf, Erik ^a   Spurkland, Anne ^b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d Molecular Biology and Genetics   (United States)

Author keywords

CD28; CTLA4; Genetic predisposition to disease; ICOS; Sclerosing cholangitis

Indexed keywords

CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNITY; CD28 GENE; CHROMOSOME 2Q; CONTROLLED STUDY; CTLA4 GENE; DNA FLANKING REGION; FEMALE; GENE; GENE CLUSTER; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; ICOS GENE; IMMUNOREGULATION; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; POLYMERASE CHAIN REACTION; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, DIFFERENTIATION; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CHILD; CHOLANGITIS, SCLEROSING; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; NORWAY;

EID: 33646478281     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520500377870     Document Type: Article

References (25)

1. Chapman RW, Arborgh BA, Rhodes JM, Summerfield JA, Dick R, Scheuer PJ, et al. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut 1980;21:870-7.
2. Bergquist A, Ekbom A, Olsson R, Kornfeldt D, Lööf L, Danielsson A, et al. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol 2002;36:321-7.
3. Fausa O, Schrumpf E, Elgjo K. Relationship of inflammatory bowel disease and primary sclerosing cholangitis. Semin Liver Dis 1991;11:31-9.
4. Saarinen S, Olerup O, Broomé U. Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis. Am J Gastroenterol 2000;95:3195-9.
5. Cullen S, Chapman R. Primary sclerosing cholangitis. Autoimmun Rev 2003;2:305-12.
6. Donaldson PT, Norris S. Immunogenetics in PSC. Best Pract Res Clin Gastroenterol 2001;15:611-27.
7. Donaldson PT. Genetics of autoimmune and viral liver diseases; understanding the issues. J Hepatol 2004;41:327-32.
8. Ling V, Wu PW, Finnerty HF, Agostino MJ, Graham JR, Chen S, et al. Assembly and annotation of human chromosome 2q33 sequence containing the CD28, CTLA4, and ICOS gene cluster: analysis by computational, comparative, and microarray approaches. Genomics 2001;78:155-68.
9. Rudd CE, Schneider H. Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling. Nat Rev Immunol 2003;3:544-56.
10. Kristiansen OP, Larsen ZM, Pociot F. CTLA-4 in autoimmune diseases: a general susceptibility gene to autoimmunity? Genes Immun 2000;1:170-84.
11. Agarwal K, Jones DE, Daly AK, James OF, Vaidya B, Pearce S, et al. CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis. J Hepatol 2000;32:538-41.
12. Agarwal K, Czaja AJ, Jones DE, Donaldson PT. Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis. Hepatology 2000;31:49-53.
13. Saarinen S, Broome U, Liger A, Olsson R, Hultcrantz R, Olerup O. CTLA-4 gene polymorphism associated with primary sclerosing cholangitis (PSC). J Hepatology 1998;28 Suppl 1:24.
14. Agarwal K, Hudson M, Harrison P, Straussbourg C, Manns MP, Donaldson P. No association between primary sclerosing cholangitis (PSC) and CTLA-4 gene polymorphism: evidence against an autoimmune aetiology? Hepatology 2000;32 Suppl 1:173A.
15. Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003;423:506-11.
16. Schneider S, Roessli D, Excoffei L. Arlequin. Genetics and Biometry Laboratory, University of Geneva, Switzerland; 2000.
17. Klitz W, Stephens JC, Grote M, Carrington M. Discordant patterns of linkage disequilibrium of the peptide-transporter loci within the HLA class II region. Am J Hum Genet 1995;57:1436-44.
18. Blomhoff A, Lie BA, Myhre AG, Kemp EH, Weetman AP, Akselsen HE, et al. Polymorphisms in the cytotoxic T lymphocyte antigen-4 gene region confer susceptibility to Addison's disease. J Clin Endocrinol Metab 2004;89:3474-6.
19. Wiencke K, Spurkland A, Schrumpf E, Boberg KM. Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles. Hepatology 2001;34:625-30.
20. Ban Y, Davies TF, Greenberg DA, Kissin A, Marder B, Murphy B, et al. Analysis of the CTLA-4, CD28, and inducible co-stimulator (ICOS) genes in autoimmune thyroid disease. Genes Immun 2003;4:586-93.
21. Colhoun HM, McKeigue PM, Davey SG. Problems of reporting genetic associations with complex outcomes. Lancet 2003;361:865-72.
22. Wood JP, Pani MA, Bieda K, Meyer G, Usadel KH, Badenhoop K. A recently described polymorphism in the CD28 gene on chromosome 2q33 is not associated with susceptibility to type 1 diabetes. Eur J Immunogenet 2002;29:347-9.
23. Hampe J, Grebe J, Nikolaus S, Solberg C, Croucher PJ, Mascheretti S, et al. Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study. Lancet 2002;359:1661-5.
24. Donaldson PT, Norris S. Evaluation of the role of MHC class II alleles, haplotypes and selected amino acid sequences in primary sclerosing cholangitis. Autoimmunity 2002;35:555-64.
25. Wiencke K, Louka AS, Spurkland A, Vatn M, Schrumpf E, Boberg KM. Association of matrix metalloproteinase-1 and -3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients. J Hepatol 2004;41:209-14.